DUTY FREE INTERNATIONAL LIMITED (8M4R)
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Notification Form for Director in respect of Interests in Securities
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Notification Form for Director in respect of Interests in Securities
Net Asset Value(s)
UTHR: United Therapeutics Corporation Announces FDA Approval of theLungFX™ Device for Centralized Ex Vivo Lung Perfusion
Mandatory Warrant Exercise :
Mandatory Warrant Exercise :
Mandatory Warrant Exercise :
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Notification Form for Director in respect of Interests in Securities
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Interest / Changes in Interest - Lim Wee Kian
Financial Statements and Related Announcement: Profit Guidance
General Announcement: Notice to Warrantholders - Expiry of Warrants on 29 June 2026